FTY720 in immuno-regenerative and wound healing technologies for muscle, epithelial and bone regeneration
In 2010, the FDA approved the administration of FTY720, S1P lipid mediator, as a therapy to treat relapsing forms of multiple sclerosis. FTY720 was found to sequester pro-inflammatory lymphocytes within the lymph node, preventing them from causing injury to the central nervous system due to inflamma...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2023-05-01
|
| Col·lecció: | Frontiers in Physiology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fphys.2023.1148932/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|